Semaglutide is an injectable prescription medication for weight loss. By imitating a natural hormone in the body, it enhances insulin secretion while moderating the pace of stomach emptying.

This leads to appetite suppression, resulting in prolonged feelings of fullness, ultimately aiding in reduced food intake and weight loss. The medication was initially sanctioned in 2017 at a lower dosage to manage blood sugar levels in individuals with Type 2 diabetes.

Those using Semaglutide for blood sugar control experienced incidental weight loss. Following research involving higher dosages of the medication in individuals without Type 2 diabetes, the FDA granted approval for Semaglutide’s use in weight loss among eligible adults.